Category: Events

GapSummit 2019

Broad Institute of Harvard and MIT, USA
June 16-20th 2019

GapSummit is the premier, global, intergenerational biotechnology summit that attracts world leaders and the next generation of leaders to substantively discuss pressing challenges facing the bioeconomy and catalyze innovation to address these challenges.

GapSummit competitively selects 100 Leaders of Tomorrow from around the world to attend the summit. We look for students, entrepreneurs and young professionals with a proven track record of leadership and expertise in the biotech field. GapSummit 2019 will provide Leaders of Tomorrow with an unparalleled opportunity to network with, challenge and learn from current world leaders in the biotech field. Leaders of Tomorrow will also gain a comprehensive overview of biotech trends and issues, inciting discussion about world challenges that will to be met by scientific and business innovations.

https://gapsummit.com

 

MIBio 2018: Stability of biopharmaceuticals – from molecular interactions to successful products

Thursday 15th November Downing College, Cambridge

The MIBio conference series engages world leading experts from industry and academia in a discussion in how the latest molecular interaction based discoveries can be exploited in biopharmaceutical formulation to produce more effective, patient-friendly and safer therapeutic products.

With growing competition in the market, patient-centric product strategies, an increasing variety of products in development and more complex regulatory requirements, the demand for formulation of therapeutic proteins are increasing. In addition, the formulation patent landscape is becoming more complicated which further contributes to the challenge of development robust dosage forms. MIBio 2018 will focus on discussing these challenges as well as strategies to overcome them, particularly focusing on formulation, drug product development and device and regulatory strategies.We expect more than 100 delegates from industry and academia to create an interesting and stimulating event fostering new collaborations and discoveries that will help steer the development of the next generation formulation technologies. We will be inviting abstracts for poster submissions and welcome applications for sponsor and exhibitor slots on the day.

Student registration only £35!
More details https://www.formulation.org.uk/mibio-2018-information

 

Fujifilm Diosynth Biotechnologies Open Innovation Event

30 November 2018, 9.30am–4.00pm, Wilton Centre, Redcar

This event is an opportunity for small and medium sized businesses, spin-out companies and academics to meet key FDB personnel and find out more about our innovation strategy and open innovation opportunities. Companies are invited to pitch their technology-driven products, services or processes to FDB. This is a great opportunity for potential business partnerships with FDB to be formed. The networking sessions are also a chance to make new contacts and discover technologies that other businesses are developing. A tour of the FDB labs is also included.

Places are limited to register your interest ASAP. Closing date for applications is October 31st 2018. For any enquiries please email Jennifer.vanderhoven@fujifilm.com
Please complete the online application at https://goo.gl/forms/bbDUGgdYSw85XTg42

5th Annual Science Meeting

October 10-11th 2018
British Medical Association House, Central London

Thank you to everyone who made this meeting a huge success. Photos will be shared with members once the photos are ready.

Wednesday October 10th
9.30 Registration
10.15-10.30 Welcome, achievements and what next for BioProNET
Designing more efficient cell-expression systems chaired by Mark Smales
10.30-10.55 Kerstin Otte
 University of Applied Science Biberach, Germany Identification and characterisation of intracellular production bottlenecks in CHO cells producing complex biopharmaceuticals
10.55-11.20 Colin Robinson University of Kent Development of next generation E. coli platforms for the regulated production and periplasmic targeting of biotherapeutics
11.20-11.45 Tarit Mukhopadhyay University College London Manufacturing the future at less than a $1 a dose and meeting global health needs
11.45-11.55 Andrew Peden University of Sheffield Developing a toolkit for determining the manufacturability of new therapeutics in CHO cells 
11.55-12.20 Nathan Lewis University of California San Diego, USA Engineering CHO cells with enhanced traits with multiplex genome editing

Building expression systems into optimised process chaired by Yvonne Genzel
13.25-13.50 Gary Finka GlaxoSmithKline Developing a next-generation cell line development platform through targeted automation, analytics and informatics
13.50-14.15 Sophia Hober Royal Institute of Technology, Sweden The human secretome project
14.15-14.25 Mayur Parekh Teesside University Improved preservation of biologics by continuous intensified lyophilisation
14.25-14.35 James Winterburn University of Manchester From bench to business with UKRI funding
14.35–15.00 Natalio Krasnogor Newcastle University Synthetic portabolomics: bridging the gap between the lab bench and industry to speed up the development of new biotech products

The clinic and beyond chaired by Laura Palomares
15.40-16.05 Caroline Barelle Elasmogen soloMERä Biologics: Site-specific therapeutic biologics for the treatment of inflammatory disease
16.05-16.20 Simon Saxby Leaf Expression Systems Plant produced biologics – process economics
16.20-16.30 Michael Plevin University of York Can an archaeal helicase enhance the performance of a nanopore DNA sequencer?
16.30-16.40 Pavlos Kotidis Imperial College London A mathematical model to describe CHO cell growth and monoclonal antibody glycosylation

18.00 Poster session
20.00 Conference dinner

Thursday October 11th
Upstream meets downstream – rapid process development chaired by Cleo Kontoravdi
9.00-9.25 Paul Dalby University College London Analysis and control of protein dynamics and stability: downstream to formulation
9.25-9.50 Yvonne Genzel Max Planck Institute for Dynamics of Complex Technical Systems, Germany Intensified cell-based viral vaccine processes: from continuous to perfusion and to hybrid systems
9.50-10.15 Maiken Kristiansen MedImmune Nucleic acid production for biotherapeutics
10.15-10.25 Dave Brockwell University of Leeds Investigating the effects of hydrodynamic force on the structure and biological integrity of a viral vector gene therapy product
10.25-10.35 Davide Vito University of Kent Translation engineering through the non-coding genome in CHO cells
10.35-11.00 Pernille Harris Technical University of Denmark Solution structure and self-association of pharmaceutical proteins

Molecular characterisation of process quality chaired by Alan Dickson
11.40-12.05 Mike Betenbaugh Johns Hopkins University, USA Glycoengineering of mammalian cell lines to improve product quality
12.05-12.30 Laura Palomares National Autonomous University of Mexico Challenges of bringing recombinant vaccines to the market: A case study for a influenza vaccine
12.30-12.40 Perdita Barran University of Manchester Top-down mass spectrometry methods for full characterisation of biopharmaceuticals
12.40-12.50 Rosa Morra University of Manchester Classical and non-classical secretion pathways in E. coli for periplasmic and extracellular recombinant protein production
12.50-13.15 Jonathan Bones The National Institute for Bioprocessing Research and Training, Ireland Characterisation of biopharmaceuticals using intact protein separations hyphenated to high resolution native mass spectrometry

 

 

 

Gordon Research Conference: Development of biotherapeutics & vaccines

 Hotel Galvez, Texas Gulf coast in Galveston, Texas, USA January 6-10th 2019

https://www.grc.org/biotherapeutics-and-vaccines-development-conference/2019/

Graduate students and post-docs can apply for waiver of registration fee (covers boarding and lodging at the hotel) from the GRC Chairs’ Fund; travel will not be reimbursed. Applications are currently being accepted through the conference web page online, and acceptances will start after the final program is posted in September.

 

Keynote Session: Vaccines and Biotherapeutics Development: Improving Global Healthcare
Brian Kelley (Vir Biotechnology, USA)
Susan Hershenson (Bill and Melinda Gates Foundation, USA)
Gail Wasserman (MedImmune, USA)
Jim Thomas (Just Biotherapeutics, USA)